Parveen Shagufta, Singh Shishu Pal, Panicker M M, Gupta Pawan Kumar
Manipal Academy of Higher Education, School of Regenerative Medicine, GKVK post, Bellary Road, Bengaluru, Karnataka, 560065, India.
National Centre for Biological Sciences, TIFR, Bangalore, India.
In Vitro Cell Dev Biol Anim. 2019 Apr;55(4):272-284. doi: 10.1007/s11626-019-00321-y. Epub 2019 Feb 24.
Recent approaches of using decellularized organ matrices for cardiac tissue engineering prompted us to culture human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (CMs) on the human amniotic membrane (hAM). Since hAM has been used lately to patch diseased hearts in patients and has shown anti-inflammatory and anti-fibrotic benefits, it qualifies as a cardiac compatible and clinically relevant heart tissue scaffold. The aim of this study was to test the ability of the hAM to support attachment, differentiation, and maturation of hiPSC-derived CMs in vitro. hAMs were prepared from term placenta. An in-house generated hiPSC line was used for CM derivation. hiPSC-derived cardiac progenitors were cultured on the surface of cryopreserved hAMs and in the presence of cytokines promoting cardiac differentiation. CMs grown on hAM and popular basement membrane matrix (BMM) Matrigel™ were compared for the following aspects of cardiac development: the morphology of cardiomyocytes with respect to shape and cellular alignments, levels of cardiac-related gene transcript expression, functionality in terms of spontaneous calcium fluxes and mitochondrial densities and distributions. hAM is biocompatible with hiPSC-derived CMs. hAM increased cardiac transcription regulator and myofibril protein transcript expression, accelerated intracellular calcium transients, and enhanced cellular mitochondrial complexity of its cardiomyocytes in comparison to cardiomyocytes differentiated on Matrigel™. Our data suggests that hAM supports differentiation and improves cardiomyogenesis in comparison to Matrigel™. hAMs are natural, easily and largely available. The method of preparing hAM cardiac sheets described here is simple with potential for clinical transplantation. Graphical abstract A An outline of the differentiation protocol with stage-specific growth factors and culture media used. B Cell fates from pluripotent stem cells to cardiomyocytes during differentiation on the amniotic membrane. C-FPhotomicrographs of cells at various stages of differentiation. Scale bars represent 100 μm.
近期利用去细胞化器官基质进行心脏组织工程的方法促使我们在人羊膜(hAM)上培养人诱导多能干细胞(hiPSC)来源的心肌细胞(CMs)。由于hAM最近已被用于修补患者患病的心脏,并显示出抗炎和抗纤维化的益处,因此它有资格作为一种与心脏兼容且具有临床相关性的心脏组织支架。本研究的目的是测试hAM在体外支持hiPSC来源的CMs附着、分化和成熟的能力。hAM由足月胎盘制备。使用内部生成的hiPSC系进行CM的分化。将hiPSC来源的心脏祖细胞培养在冷冻保存的hAM表面,并在促进心脏分化的细胞因子存在的情况下培养。比较在hAM和常用的基底膜基质(BMM)基质胶™上生长的CMs在心脏发育的以下方面:心肌细胞的形态,包括形状和细胞排列、心脏相关基因转录本表达水平、自发钙流和线粒体密度及分布方面的功能。hAM与hiPSC来源的CMs具有生物相容性。与在基质胶™上分化的心肌细胞相比,hAM增加了心脏转录调节因子和肌原纤维蛋白转录本的表达,加速了细胞内钙瞬变,并增强了其心肌细胞的细胞线粒体复杂性。我们的数据表明,与基质胶™相比,hAM支持分化并改善心肌生成。hAM是天然的,易于大量获取。本文所述的制备hAM心脏片的方法简单,具有临床移植的潜力。图形摘要A使用的具有阶段特异性生长因子和培养基的分化方案概述。B在羊膜上分化过程中从多能干细胞到心肌细胞的细胞命运。C - F分化各阶段细胞的显微照片。比例尺代表100μm。